Jeanne Loring, PhD

Jeanne Loring, PhD

Scripps Research Institute

Jeanne F. Loring is Professor emeritus at the Scripps Research Institute where she was founding Director of the Center for Regenerative Medicine. Dr. Loring has diverse experience: 15 years in biotechnology and 15 years of academic research, combining stem cells, genomics, epigenetics, bioinformatics, embryology and neurobiology. She has founded two stem cell-based biotechnology companies, Arcos Bioscience (now part of Viacyte) and Aspen Neuroscience, a biotechnology company founded in 2018 to continue development of an autologous neuron replacement therapy for Parkinson disease.  She holds five patents on stem cells and genomics, and has published three books and more than 120 research articles.

In addition to her work on Parkinson disease, Dr. Loring investigates stem cell-based therapies for multiple sclerosis, studies the cellular basis for autism, and works with the San Diego Zoo Institute for Conservation Research in an effort to rescue the Northern white rhinoceros from extinction using stem cell technology.  She is also involved in a project on the International Space Station to study neurogenerative disease in microgravity.

Dr. Loring is recipient of many awards for her accomplishments both as a scientist and an advocate for evidence-based therapies for patients and education. Through her NIH- and CIRM-sponsored laboratory courses, she has trained more than 400 scientists in stem cell technology. She serves on bioethics and scientific advisory boards, is on the editorial boards of several scientific journals, and advises governmental and private granting agencies in several countries. She is frequently interviewed for news reports about topics including cell and gene therapies, patient rights, the ethics of stem cell tourism, experiments in space, rescue of endangered species, and challenges for women in science and as entrepreneurs in biotechnology. She gives talks about her work at international conferences, is the featured speaker on numerous podcasts and webinars, is interviewed often by television networks, and hasappeared in several documentaries.